739 related articles for article (PubMed ID: 8610364)
21. A novel application of cyclosporine A in nonmyeloablative pretransplant host conditioning for allogeneic BMT.
Nikolic B; Zhao G; Swenson K; Sykes M
Blood; 2000 Aug; 96(3):1166-72. PubMed ID: 10910938
[TBL] [Abstract][Full Text] [Related]
22. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
Tomita Y; Sachs DH; Sykes M
Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
[TBL] [Abstract][Full Text] [Related]
23. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
[TBL] [Abstract][Full Text] [Related]
24. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
[TBL] [Abstract][Full Text] [Related]
25. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning.
Exner BG; Colson YL; Li H; Ildstad ST
Surgery; 1997 Aug; 122(2):221-7. PubMed ID: 9288126
[TBL] [Abstract][Full Text] [Related]
26. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
27. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.
Sharabi Y; Sachs DH
J Exp Med; 1989 Feb; 169(2):493-502. PubMed ID: 2562984
[TBL] [Abstract][Full Text] [Related]
28. Highly disparate xenogeneic skin graft tolerance induction by fetal pig thymus in thymectomized mice: Conditioning requirements and the role of coimplantation of fetal pig liver.
Zhao Y; Rodriguez-Barbosa JI; Swenson K; Zhao G; Arn JS; Sykes M
Transplantation; 2001 Nov; 72(10):1608-15. PubMed ID: 11726819
[TBL] [Abstract][Full Text] [Related]
29. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells.
Lee LA; Sergio JJ; Sykes M
Transplantation; 1996 Jan; 61(1):125-32. PubMed ID: 8560550
[TBL] [Abstract][Full Text] [Related]
31. Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning.
Kim YM; Mapara MY; Down JD; Johnson KW; Boisgerault F; Akiyama Y; Benichou G; Pelot M; Zhao G; Sykes M
Blood; 2004 Jan; 103(2):732-9. PubMed ID: 14512313
[TBL] [Abstract][Full Text] [Related]
32. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
[TBL] [Abstract][Full Text] [Related]
33. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
Truitt RL; Atasoylu AA
Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
[TBL] [Abstract][Full Text] [Related]
34. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
35. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.
Aksentijevich I; Sachs DH; Sykes M
Transplantation; 1992 May; 53(5):1108-14. PubMed ID: 1585475
[TBL] [Abstract][Full Text] [Related]
36. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.
Huang CA; Fuchimoto Y; Scheier-Dolberg R; Murphy MC; Neville DM; Sachs DH
J Clin Invest; 2000 Jan; 105(2):173-81. PubMed ID: 10642595
[TBL] [Abstract][Full Text] [Related]
37. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
[TBL] [Abstract][Full Text] [Related]
38. Influence of graft versus host reaction on the T cell repertoire differentiating from bone marrow precursors following allogeneic bone marrow transplantation.
Onoé K; Arase N; Arase H; Takayanagi T; Nishihori H; Iwabuchi K; Ogasawara K; Good RA
Transpl Immunol; 1997 Jun; 5(2):75-82. PubMed ID: 9269028
[TBL] [Abstract][Full Text] [Related]
39. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
[TBL] [Abstract][Full Text] [Related]
40. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
